Roger Cone

Board Member at Courage Therapeutics

Dr. Cone, Director of the Life Sciences Institute at the University of Michigan, is the founding scientist of Courage. He is a member of the National Academy of Sciences with a deep focus in the biology of the melanocortin system and the molecular basis of feeding behaviors. Throughout his career his lab established the key intellectual property for novel uses of these receptors in eating disorders and obesity. Dr. Cone has a track record of translating his research into commercial ventures including Northwest Neurologic acquired by Neurocrine Biosciences (NASDAQ:NBIX).

Timeline

  • Board Member

    Current role